TARA Q4 2024 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$228M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-0.48

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$904,000

Balance Sheet

Total Assets

$181M

Total Liabilities

$14M

Stockholders' Equity

$167M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$14M	-$11M	-29.6%
Net Income	-$13M	-$10M	-24.9%